Cytokine Polymorphisms and Treatment Outcomes in SLE Patients
Author Information
Author(s): López Patricia, Gómez Jesús, Mozo Lourdes, Gutiérrez Carmen, Suárez Ana
Primary Institution: Department of Functional Biology, Area of Immunology, University of Oviedo
Hypothesis
The study aims to analyze the effect of antimalarial treatment on TNFα serum levels and evaluate the influence of TNFα and IL-10 genetic polymorphisms on the response to antimalarial drugs.
Conclusion
Antimalarial treatment is associated with lower TNFα serum levels in SLE patients, influenced by genetic polymorphisms at the IL-10 and TNFα gene promoters.
Supporting Evidence
- SLE patients receiving antimalarial drugs had TNFα levels similar to healthy controls.
- Untreated SLE patients had significantly higher TNFα levels compared to those on antimalarial treatment.
- The low IL-10/high TNFα genotype was associated with better responses to antimalarial therapy.
Takeaway
This study found that certain genes can help predict how well lupus patients will respond to antimalarial drugs.
Methodology
The study quantified TNFα serum levels in SLE patients and healthy controls and analyzed genetic polymorphisms using PCR and hybridization techniques.
Limitations
The study lacked a prospective longitudinal analysis of TNFα levels before and after treatment and did not use standardized measures of SLE activity.
Participant Demographics
All participants were Caucasian and met the ACR criteria for SLE.
Statistical Information
P-Value
p = 0.020
Confidence Interval
95% CI 1.11–4.58
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website